Related Experiment Video
Updated: Jan 17, 2026
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.5K
External Comparator Cohort studies - clarification of terminology
Gerd Rippin1, Joan Largent2, Wilhelmina Elisabeth Hoogendoorn3
1IQVIA, Biostatistics, Frankfurt, Germany.
Frontiers in Drug Safety and Regulation
|September 22, 2025
Summary
Standardizing terminology for research using external data is crucial. We propose clear terms like Externally Controlled Trial and External Comparator study for better clarity and credibility in scientific research.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Regulatory Science
Background:
- Diverse terminology exists for controlled research using external data, unlike the single term for Randomized Controlled Trials.
- Common terms include External Comparator/Control Arm study, Externally Controlled Trial, Synthetic Control study, and Historical Control study.
Purpose of the Study:
- To propose a standardized nomenclature for research involving external data.
- To differentiate between pre-specified and non-pre-specified external data use.
- To enhance transparency and credibility in clinical research.
Main Methods:
- Analysis of existing terminology for controlled research with external data.
- Proposal of specific terms based on pre-specification of data and analysis.
- Development of a general framework for nomenclature in external data research.
Main Results:
- The term Externally Controlled Trial is suitable for pivotal trials with pre-specified external data.
- External Comparator Cohort study is proposed for research without pre-specification.
- A framework for consistent terminology is presented.
Conclusions:
- Precise and consistent terminology is essential to avoid misinterpretation in research using external data.
- Adoption of proposed nomenclature will improve clarity and credibility.
- Standardized terms support robust scientific communication and regulatory alignment.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
01:27Confounding in Epidemiological Studies
582
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
582
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
01:16Bioequivalence Data: Statistical Interpretation
194
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
194
01:29Bias in Epidemiological Studies
1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.3K
01:50Cross-Sectional Research
12.4K
In cross-sectional research, a researcher compares multiple segments of the population at the same time. If they were interested in people's dietary habits, the researcher might directly compare different groups of people by age. Instead of following a group of people for 20 years to see how their dietary habits changed from decade to decade, the researcher would study a group of 20-year-old individuals and compare them to a group of 30-year-old individuals and a group of 40-year-old...
12.4K